C 18 H 18 BrN 6 Re, monoclinic, P2 1 /n (no. 14), a =11.0894 ( 
Next to cardiovascular diseases, cancer has become one of the main fatal diseases in industrialized countries. Apart fromclassical surgery,chemo-and radiotherapeutic treatments have entered the arsenal of possible cures for certain types of cancer. All methods, however, suffer from theirown setofproblematic side-effects and, as ac onsequence, the development of radiopharmaceuticals -combining the advantages of chemotherapy as well as radiation methods while at the sametimeavoiding their unique respectivendesiredside-effects -has been atopic of research [1, 2] . Tailoring and fine-tuning of the envisioned radiopharmaceuticals' properties such as lipophilicity and, in particular, inertness is of paramount importance with respect to possible future in vivo applications in contemporary medicine and requires sound knowledge about structural parameters of the ligands applied if a more heuristic approach in the synthesis is to triumph over pure trial-and-error as it is encountered in this specific field of coordination chemistry up to the present day. In addition, the spatial requirements of pharmaceuticalsa re of importance as this factor influences on their interaction with enzymatic systems and, as a consequence, thep athway and rateo fc onjugation, functionalization and secretion from the body. In continuation of our ongoing research on the field of rhenium coordination compounds, the coordination of amultidentate ligand towards arhenium(V) startingm aterial was attempted [3] .As tructural analysis of the crystalline reaction product showed the formation of an unexpected product. The crystal structures of two other comparable rhenium coordination compounds as found in the current reaction product are apparent in the literature [4] .T he compound is ahomoleptic rhenium(VII) coordination compound featuringt hree chelating ortho-phenylenediamine ligands that are invariably two-folddeprotonated. The positive charge of the coordination unit is balanced by ab romide anionpresent in the crystal structure. Ac onformational analysis of the fivemembered chelate rings according to Cremer &Pople [5] shows the latter to invariably adopt E 1 conformations on the rhenium atom [6] .R e-N bond lengthsc over an arrowr ange of 1.991(2)-2.0106(19) Åonly.The least-squares planes as defined by therespective carbon atomsofeach aromatic moiety enclose anglesof45.82(7)°,65.94(8)°and 68.82(9)°. In the crystal, classical hydrogen bonds of the N-H×××Br type are observed next to C-H×××Nc ontacts whose range falls below the sum of van-derWaals radii of the atomsparticipating in them [7] . Theclassical hydrogen bondsare only supportedbybothNHgroupseachof twoofthe chelatingligandsonlywhile onechelating ligand does notp articipatei nt he formationo fa ny intra-or intermolecular contacts whatsoever. The C-H×××Nc ontact involves one CH group in ortho position to the functional groups of one of the two ligands whose NH groups give rise to N-H×××Br hydrogen bonds already.The latter contact could also be considered to be the result of the orientation of the molecules in the crystal as fostered by the N-H×××Br contacts. In terms of graph-set analysis [8, 9] , the descriptor for the classical hydrogen bonds is DDDD on the unary level while the C-H×××Ncontacts necessitate a C 1 1 (6)descriptor on thesamelevel. In total, the entities of the title compound are connected to undulated chains along the crystallographic b axis. Furthermore, three C-H×××p contacts could be discussed alsoinvolving hydrogen atomsofthe chelating ligand whose NH groups were not part of the system of classical hydrogen bonds. The shortest intercentroid distance between two centers of gravity in neighbouring molecules was measured at 3.5271(13) Å. Re (1) 4e 0.270752(9) 0.186802 (7) 0.815591 (7) 
